210 related articles for article (PubMed ID: 1578905)
41. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
42. Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy.
Gutierrez A; Kentsis A
Br J Haematol; 2018 Mar; 180(6):919-924. PubMed ID: 29441563
[TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
44. Multifaceted approach to the diagnosis and classification of acute leukemias.
McKenna RW
Clin Chem; 2000 Aug; 46(8 Pt 2):1252-9. PubMed ID: 10926919
[TBL] [Abstract][Full Text] [Related]
45. Immunophenotyping in the diagnosis and classification of acute leukaemia.
McLellan G; Bird AR; Jacobs P
S Afr Med J; 1989 Dec; 76(12):650-3. PubMed ID: 2595503
[TBL] [Abstract][Full Text] [Related]
46. Pathology and immunology of acute leukemia.
Mirro J
Leukemia; 1992 Nov; 6 Suppl 4():13-5. PubMed ID: 1434816
[TBL] [Abstract][Full Text] [Related]
47. Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. II. Studies with monoclonal antibodies and terminal transferase.
San Miguel JF; Tavares de Castro J; Matutes E; Rodriguez B; Polli N; Zola H; McMichael AJ; Bollum FJ; Thompson DS; Goldman JM
Br J Haematol; 1985 Feb; 59(2):297-309. PubMed ID: 3882137
[TBL] [Abstract][Full Text] [Related]
48. Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype.
Vidriales MB; Orfao A; López-Berges MC; González M; López-Macedo A; García MA; Galende J; San Miguel JF
J Clin Pathol; 1995 May; 48(5):456-62. PubMed ID: 7629293
[TBL] [Abstract][Full Text] [Related]
49. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D
Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640
[TBL] [Abstract][Full Text] [Related]
50. Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.
Saksena A; Gautam P; Desai P; Gupta N; Dubey AP; Singh T
Indian J Med Res; 2016 May; 143(Supplement):S17-S22. PubMed ID: 27748273
[TBL] [Abstract][Full Text] [Related]
51. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
[TBL] [Abstract][Full Text] [Related]
52. Double esterase staining of the bone marrow contributes to lineage identification in a case of minimally differentiated acute myeloid leukaemia (AML M0).
Elghetany MT
Clin Lab Haematol; 1999 Aug; 21(4):293-5. PubMed ID: 10583335
[TBL] [Abstract][Full Text] [Related]
53. The role of an anti-myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry.
Buccheri V; Shetty V; Yoshida N; Morilla R; Matutes E; Catovsky D
Br J Haematol; 1992 Jan; 80(1):62-8. PubMed ID: 1311196
[TBL] [Abstract][Full Text] [Related]
54. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
Billing RJ; Foon KA; Linker-Israeli M
Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
[TBL] [Abstract][Full Text] [Related]
55. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia.
Matutes E; Pombo de Oliveira M; Foroni L; Morilla R; Catovsky D
Br J Haematol; 1988 Jun; 69(2):205-11. PubMed ID: 3390393
[TBL] [Abstract][Full Text] [Related]
56. Biphenotypic M0 acute myeloid leukemia with trisomy-4.
Keung YK; Kaplan B; Douer D
Leuk Lymphoma; 1994 Jun; 14(1-2):181-4. PubMed ID: 7522717
[TBL] [Abstract][Full Text] [Related]
57. Quantitative expression of thrombopoietin receptor on leukaemia cells from patients with acute myeloid leukaemia and acute lymphoblastic leukaemia.
Takeshita A; Shinjo K; Izumi M; Ling P; Nakamura S; Naito K; Ohnishi K; Ohno R
Br J Haematol; 1998 Feb; 100(2):283-90. PubMed ID: 9488614
[TBL] [Abstract][Full Text] [Related]
58. Mixed-phenotype acute leukemia: historical overview and a new definition.
Weinberg OK; Arber DA
Leukemia; 2010 Nov; 24(11):1844-51. PubMed ID: 20844566
[TBL] [Abstract][Full Text] [Related]
59. The characterisation of leukaemias with the Sysmex NE-8000.
van der Meer W; Swinkels DW; Willems HL
Acta Haematol; 1997; 98(4):195-8. PubMed ID: 9401496
[TBL] [Abstract][Full Text] [Related]
60. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
Paietta E; Racevskis J; Bennett JM; Wiernik PH
Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
